The Pandemic Can’t End While Wealthy Nations Hoard Shots
Eliminating Covid globally means navigating a minefield of competition, limited supply, and suspicion that some vaccines aren’t as good. More
Blog
Avoiding a ‘gender recession’: New report details how the pandemic has impeded women’s STEMM careers
A recent report finds the pandemic has impeded the careers of women in academic science, technology, math, and medicine fields. More
Without a Pandemic Safety Net, Immigrants Living in US Illegally Fall Through the Cracks
The Migration Policy Institute, a nonprofit think tank in Washington, D.C., reported in January that 9.3 million unauthorized immigrants whose income meets the threshold for covid aid are blocked from accessing it, and also can’t apply for federal programs that provide cash and food assistance. More
Opinion | Vaccine hesitancy is not the problem among people of color. It’s vaccine access.
It's time for public health officials to flip the script on vaccine equity. More
Prevalence of Central Nervous System–Active Polypharmacy Among Older Adults With Dementia in the US
This pharmacoepidemiology study uses Medicare claims data to describe the prevalence of central nervous system–active polypharmacy among community-dwelling older adults with dementia in the US, including durations of exposure and number of drugs and drug classes. More
Opinion | We Did Not Suffer Equally
The pandemic has not been a story of an infection curve rising and falling, but of two lines — the haves and have-nots — moving in different directions. More
The impact of the globalization of cancer clinical trials on the enrollment of Black patients
Cancer clinical trials conducted primarily outside of the United States are 2‐fold less likely to enroll Black participants than are clinical trials conducted within the United States. More
Op-ed: Mercy Hospital’s survival is crucial to the pregnant women it serves
If the deal with Insight falls through and Mercy closes, the impact on its surrounding communities will be devastating. More
Researchers Attempt to Reduce the Placebo Effect in Drug Trials
Pharmaceutical company researchers develop a tool to suppress the placebo effect and improve their drug results. More
Opinion: Too many medicines can be its own medical hazard
Over-medication can be dangerous and patients should consult with medical professions to ensure an effective plan of treatment, Dr. Bob Newman writes in a guest column. More
Can we put a ceiling on hospital prices?
In JAMA, Michael Chernew and Maximilian Pany argue that a price cap on the higher end of hospital prices would save tens of billions. More
Covid-19 conflicts of interest go beyond pharma
Dr. Vivek Murthy, Biden's pick for surgeon general, was recently found to have accepted significant consulting payments from private companies. Should this disqualify him from the position? More
How One Firm Put an ‘Extraordinary Burden’ on the U.S.’s Troubled Stockpile
The shortage of lifesaving medical equipment last year was a searing example of the government’s failed coronavirus response. As health workers resorted to wearing trash bags, one Maryland company profited by selling anthrax vaccines to the country’s emergency reserve. More
One U.S. State’s Laser Focus on Data Helps Shrink Racial Vaccine Gap
North Carolina has racial data for 99.6% of people who got a shot in the state More
I’m A Psychiatrist Who Treats Health Workers. A Year Into The Pandemic, We’re All Suffering From Burnout
About 50% of medical professionals were dealing with burnout before COVID-19, writes Dr. Jessi Gold. The pandemic has made it exponentially worse. More
‘Falling through cracks’: Vaccine bypasses some older adults
Jean Andrade, an 88-year-old who lives alone, has been waiting for her COVID-19 vaccine since she became eligible under state guidelines nearly a month ago. More
Blue Cross of Minnesota lawsuit takes aim at ‘Pharma bro’
Lawsuit alleges monopoly scheme by drug company once headed by now imprisoned Martin Shkreli. More
Comparison of Palliative Care Delivery in the Last Year of Life Between Adults With Terminal Noncancer Illness or Cancer
This cohort study examines the delivery of palliative care among adults in their last year of life who died of terminal noncancer illness compared with those who died of cancer. More
Widely used convalescent plasma treatment doesn’t stop COVID-19 patients from getting sicker, study finds
The treatment was authorized for emergency use last summer, but clinical trials showed plasma from recovered COVID-19 patients didn't help fight illness. More
Housing Is an Essential Part of Health Care—“Treat ‘Em and House ‘Em”
People experiencing homelessness bear a disproportionate burden of chronic illnesses and are unable to consistently practice social isolation; unsurprisingly, they have been disproportionately affected by the coronavirus disease 2019 (COVID-19) pandemic. More